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Mycobacterium tuberculosisPosttranslational modiﬁcations in the form of covalently attached proteins like ubiquitin (Ub), were long consid-
ered an exclusive feature of eukaryotic organisms. The discovery of pupylation, themodiﬁcation of lysine residues
with a prokaryotic, ubiquitin-like protein (Pup), demonstrated that certain bacteria use a tagging pathway func-
tionally related to ubiquitination in order to target proteins for proteasomal degradation. However, functional
analogies do not translate into structural or mechanistic relatedness. Bacterial Pup, unlike eukaryotic Ub, does
not adopt a β-grasp fold, but is intrinsically disordered. Furthermore, isopeptide bond formation in the pupylation
process is carried out by enzymes evolutionary descendent from glutamine synthetases. While in eukaryotes, the
proteasome is the main energy-dependent protein degradation machine, bacterial proteasomes exist in addition
to other architecturally related degradation complexes, and their speciﬁc role along with the role of pupylation is
still poorly understood. InMycobacterium tuberculosis (Mtb), the Pup–proteasome system contributes to pathoge-
nicity by supporting the bacterium's persistence within hostmacrophages. Here, we describe themechanism and
structural frameworkof pupylation and the targeting of pupylated proteins to the proteasome complex. Particular
attention is given to the comparison of the bacterial Pup–proteasome system and the eukaryotic ubiquitin–
proteasome system. Furthermore, the involvement of pupylation and proteasomal degradation inMtb pathogen-
esis is discussed togetherwith efforts to establish the Pup–proteasome system as a drug target. This article is part
of a Special Issue entitled: Ubiquitin–Proteasome System. Guest Editors: Thomas Sommer and Dieter H. Wolf.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bacterial proteasomes recruit substrates for degradation by a tagging
pathway related to eukaryotic ubiquitination (Fig. 1) [1,2]. Speciﬁc lysine
residues of target proteins are covalently modiﬁed with a small protein
termed Pup (prokaryotic ubiquitin-like protein) in a process referred
to as pupylation. The ligation of Pup to substrates via an isopeptide
bond is catalyzed by a single enzyme, the Pup ligase PafA [2,3].
Pupylation is counterbalanced by a depupylation enzyme (Dop), which
mediates the cleavage of the isopeptide bond and thus the release of
Pup from amodiﬁed protein [4,5]. Interestingly, the depupylase enzyme
Dop and the Pup ligase PafA are homologous on the sequence and struc-
tural level [3,6,7]. Pupylated proteins are recognized by the proteasome
complex due to the binding of Pup to the N-terminal coiled-coil domains
of the proteasomal ATPase [8,9]. After docking of the pupylated substrate
to the ATPase ring, engagement of Pup into the ring-pore initiates sub-
strate unfolding and leads to subsequent degradation inside the 20S
proteasome chamber [10]. The occurrence of proteasomes and the
pupylation pathway is limited to the large and diverse phylum of
actinobacteria, which includes such important pathogens as Mtb andtin–Proteasome System. Guest
rights reserved.Mycobacterium leprae. Under standard laboratory conditions, the Pup–
proteasome system is not essential in the bacteria investigated so far
[11–14]. However, Mtb makes use of this pathway to survive in the
host [15,16]. The pupylated proteome of Mtb grown in vitro includes a
broad assortment of proteins with a range of functional connotation
from intermediary metabolism, stress response and toxicity to lipid me-
tabolism [17]. Which substrate or group of substrates providesMtbwith
an advantage inside the host, though, is still unresolved to date.
2. Bacterial proteasomes
2.1. Occurrence of the 20S proteasome in bacteria
Proteasomes are the molecular workhorses of energy-dependent
protein turnover in archaeal and eukaryotic cells. The characteristic
four-tiered, cylinder-shaped particles were ﬁrst described over 25 years
ago, establishing the principle of molecular compartmentalization inside
a proteinaceous chamber rather than a cellular organelle [18]. It was
soon discovered that bacteria employ the same architectural principle
of sequestering protease active sites within cylinder-shaped particles
to avoid random access of proteins to their destructive activity [19,20].
In bacteria, multiple degradation complexes generally coexist (e.g., Clp
proteases, FtsH, Lon protease), while in eukaryotes the proteasome is
the main cytosolic degradation machine. Although functionally clearly
Fig. 1. Bacterial pupylation, like eukaryotic polyubiquitination, is a post-translationalmodiﬁcation that can render target proteins as substrates for proteasomal degradation. First, the pro-
karyotic ubiquitin-like protein Pup is attached to lysine residues of target proteins through an isopeptide bond. Tagged proteins are recognized by the proteasomal ATPase (Mpa/ARC)
which is part of the proteasome complex. TheMpa-ring (orange) uses ATPase-drivenmotion of pore loops to unfold the pupylated substrate and to translocate it into the 20S proteasome
(purple), where it is degraded into small peptides. The bacterial “Pup–proteasome system” (PPS) is thus functionally related to the “Ubiquitin proteasome system” (UPS) in eukaryotes.
Note that poly-Ub is removed by de-ubiquitinases present in the lid before degradation of the substrate. ‘Rpt’, regulatory particle ATPase. ‘Lid’, non-ATPase subunits of the regulatory 19S
particle.
104 F. Striebel et al. / Biochimica et Biophysica Acta 1843 (2014) 103–113related, the bacterial and eukaryotic degradation cylinders show only
limited homology, drawing a clear division between the bacterial and eu-
karyotic/archaeal proteolytic assemblies.
However, the large and diverse group of actinobacteria harbors
proteasomes together with the typical bacterial protease cylinders
[21,22]. Actinobacteria are an ancient phylum of gram-positive bacteria
and occupy a variety of biological niches [23]. They include pathogenic
members (Mycobacterium spp.) and eukaryotic symbionts (nitrogen-
ﬁxing or gastrointestinal species). While many have argued that the
20S proteasome was acquired by horizontal gene transfer either from
archaea or from eukaryotes [24,25], others suggest that actinobacteria
are ancestral to archaeamaking the bacterial 20S proteasome the ances-
tor of the archaeal and eukaryotic proteasomes [26].
Independent of its origin the bacterial proteasome is maintained in
most actinobacterial genomes in parallel to other energy-dependent
proteolytic systems despite the fact that it appears non-essential under
normal growth conditions in the species studied so far [11,12,27].
In the human pathogen Mtb, the causative agent of tuberculosis, the
proteasome has been identiﬁed as one of the factors that supports per-
sistence inside host macrophages [15,16,27,28]. Unlike the Clp protease
genes (clpP1, clpP2 and clpX) that are essential in Mtb [29], the Mtb
proteasome is not required for in vitro growth [27].
2.2. Bacterial 20S proteasomes and their ATPase partners
Proteins are folded and have evolved to withstand the repertoire
of small single-hit proteases present in the cell [30,31]. Hence, protein
degradation necessitates the unfolding of the target protein. Further-
more, the proteolytic active sites of the proteasome are conﬁned to
the inner walls of the 20S cylinder to avoid unspeciﬁc degradation.Therefore, the unraveled polypeptide has to be translocated into the
20S proteasome chamber (Fig. 1). This task is accomplished by ring-
shaped, hexameric ATPase complexes of the AAA family that associate
with the proteasome core cylinder.
In actinobacteria, the gene encoding the AAA unfoldase partner
of the proteasome is usually found upstream in the vicinity of the
proteasomal subunit genes (Fig. 2). This AAA unfoldase (referred to as
Mpa in mycobacteria and as ARC in other actinobacteria) shows no sig-
niﬁcant sequence similarity to other AAA proteins beyond the AAA do-
main and branches off near the root of the AAA family dendrogram
[32,33].
However, ARC/Mpa shows similarities in architecture and domain
structure to the archaeal proteasomal ATPase complex PAN as well as
to the six eukaryotic proteasomal ATPase subunits (Rpt1–6). The main
ring body is formed by the AAA modules, which are preceded
N-terminally by two OB (oligonucleotide/oligosaccharide binding) do-
mains [34]. The stable 5-stranded β-barrels of the two OB domains ar-
range each into hexameric rings creating a ﬁrm double-tiered ﬂange
(referred to also as the intermediate domain) on top of the AAA ring.
The archaeal or eukaryotic ATPases in contrast only feature one OB do-
main. For this reason, the Mpa/ARC complex is taller in appearance
based on side views of electron microscopy images [35]. As do all
proteasomal ATPases, theMpa/ARC ATPase-rings feature coiled-coil do-
mains at their N-termini [32,34,36]. The N-terminal domains of neigh-
boring subunits form a total of three coiled-coils per hexameric ring.
Like the eukaryotic proteasome, the bacterial 20S complex is ar-
ranged as a cylinder composed of four stacked 7-membered rings
(Fig. 1). The two inner β-rings carry the proteolytic active sites and
the two outer α-rings mediate the contact to the ATPase partners
[37,38]. The bacterial α- and β-subunits are structurally homologous
Fig. 2. Organization of the Pup–proteasome gene locus ofMtb. The proteasomal subunit genes prcB and prcA and the preceding pup gene are organized in an operon. The proteasomal
ATPase Mpa is encoded by a separate gene located further upstream. The gene for the deamidase/depupylase Dop is usually found directly upstream of pup, whereas the gene for the
Pup-ligase PafA is located further downstream.
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eukaryotic proteasome, where each position in the α- and the β-rings
is occupied by a distinct subunit, the bacterial 20S particle consists
of homomeric α- and β-rings. Cryo-electron microscopy of the Mtb
proteasome revealed an obstructing protuberance at the α-rings, the
so-called “proteasomal gate”, that disappears when the ﬁrst 7 residues
of the α-subunit are deleted [38].
Archaeal and eukaryotic proteasomal ATPases bind to the 20S
proteasome cylinder faces by inserting their carboxy-termini that
carry an aromatic residue in the penultimate position into binding
pockets located at the 20S α-ring surface. This leads to replacement of
the N-termini of the α subunits and thus to the opening of the 20S
gate and allows the unfolded substrate to be passed into the proteolytic
chamber of the proteasome [39,40].
The mycobacterial as well as other actinobacterial proteasomal
ATPases carry a similar C-terminal motif (QGYL) with the required aro-
matic residue in the penultimate position. Thus, a similar mechanism
for gate opening can be expected. Surprisingly, however, substantial
interaction between Mpa and the 20S core could not be demonstrated
in vitro [10,41]. Signiﬁcant interaction and consequently efﬁcient
substrate degradation in vitro are only observed when an “open gate”
variant of the proteasome is used, which lacks the seven N-terminal
residues of theα-subunits. Therefore, it is possible that either additional
factors are needed for gate-opening or that the α-N-termini of recom-
binantly produced proteasome particles exhibit a slightly different con-
formation as a consequence of missing assembly factors.
3. Pupylation or how bacteria target substrates to the proteasome
3.1. Prokaryotic ubiquitin-like protein Pup
In eukaryotes, protein substrates are recruited to the proteasome
by means of a polyubiquitin tag that is posttranslationally attached
to a lysine residue of the respective target (Fig. 1) [42–45]. Recruit-
ment of substrates to the bacterial proteasome complexes on the
other hand remained elusive until two groundbreaking studies in Mtb
and Mycobacterium smegmatis (Msm) revealed that the proteasome in
these organisms recruits protein substrates in a manner functionally
analogous to ubiquitination [1,2]. A small protein referred to as Pup
(prokaryotic ubiquitin-like protein) is posttranslationally attached to
lysine residues of target proteins, thereby directing them towards
proteasomal degradation. InMtb and someother actinobacterial species
the proteasomal subunit genes and the pup gene show overlap
suggesting translational coupling (Fig. 2) [12,22].
Although Pup and Ubiquitin (Ub) exhibit functional analogies, they
are not homologouswith respect to their amino acid sequence or struc-
ture [8,46,47]. Like Ub (76 amino acids), Pup proteins are small, ranging
from 60 to 70 residues in length. Sequence alignment shows that the
C-terminal half is well conserved, while the N-terminal half differs
considerably among different actinobacteria (Fig. 3). Another shared
feature with Ub is a conserved di-glycine motif at the C-terminal end.
In all Pup sequences, this motif is not located at the very C-terminus
as in processed Ub, but is followed by either a glutamine or a glutamate
as C-terminal residue.
Structurally, Pup differs markedly from Ub. While Ub adopts the
stable β-grasp fold [48] that has become the hallmark for Ub [49]and other ubiquitin-like modiﬁers such as SUMO or NEDD8, Pup is
mostly disordered in its unbound state as shown by NMR analysis
and circular dichroism [8,46,47]. The conserved C-terminal part con-
tains hydrophobic–hydrophilic sequence patterns characteristic for
coiled-coil formation, and NMR spectra exhibited features consistent
with weak helix formation in that region [8].
3.2. Pup-conjugation in mycobacteria—a process mediated by Dop and
PafA
The in vivo studies inMtb andMsm clearly showed that Pup, like Ub,
is conjugated through its C-terminal residue to lysine side chains of
substrates via an isopeptide bond [1,2]. However, unlike Ub, that is pro-
teolytically processed prior to its attachment to expose the C-terminal
di-glycine motif, the C-terminal glutamine of Pup was found not to be
removed upon Pup-attachment to a protein. In addition to that,MS anal-
yses showed that the mass of tryptic Pup-modiﬁed peptides differed by
1 Da from the theoretical mass, suggesting that in mycobacteria a
deamidation event might take place during or prior to the conjugation
reaction, converting Pup's C-terminal glutamine to glutamate [1,2].
In an effort to identify the components that mediate the modiﬁca-
tion of proteins with Pup, pull-down experiments with Pup-decorated
beads were performed usingmycobacterial cell lysates as prey. This ap-
proach returned two homologous proteins as speciﬁc Pup interaction
partners, namely Dop and PafA, that are both encoded as part of the
proteasomal gene cluster (Fig. 2) [3]. The observed interaction with
Pup and the close proximity of the respective genes to the proteasomal
subunit genes and the pup gene pointed towards a role in pupylation.
Indeed, in a pafA knockout strain of Mtb, pupylated proteins are
undetectable and proteasomal substrate proteins accumulate [2,50].
Further evidence for a possible function of PafA and Dop related to
Pup-attachment came from a bioinformatic study, that showed the ho-
mology of these two proteins to carboxylate-amine ligases [6]. These
enzymes catalyze for example the ligation of two amino acids via an
isopeptide bond and will be discussed in more detail in Section 3.4.
Upon incubation of Pup with the previously uncharacterized pro-
tein Dop in vitro, a characteristic downshift of Pup on a standard
SDS-PAGE gel was observed [3]. This shift could be clearly attributed
to a deamidation event on the C-terminal residue of Pup catalyzed by
Dop (deamidase of Pup), converting glutamine (PupQ) to glutamate
(PupE) (Fig. 4). Subsequently, using the recombinantly reconstituted
system it was shown that PafA is sufﬁcient to conjugate PupE, but not
PupQ, to the known mycobacterial proteasome substrates FabD and
PanB [3,50]. This unambiguously characterized PafA as the Pup-ligase.
Mycobacterial Pup conjugation is thus a two-step process: deamidation
of the C-terminal glutamine of Pup by Dop renders Pup competent for
conjugation to substrates, which is then carried out by the Pup-ligase
PafA (Fig. 4) [3]. These ﬁndings also hold true in vivo, where PupE, but
not PupQ, is able to restore pupylation in an Msm dop-knockout strain
as well as in an Mtb dop-deletion strain, albeit to a lesser degree in
Mtb [51,52]. Strikingly, several species outside the genusMycobacterium
encode Pup with a C-terminal glutamate (Fig. 3), and thus require no
deamidation event prior to conjugation. However, these species still
encode the Pup-deamidase Dop, which led to the conjecture that
Dop might have an additional function [3]. This hypothesis was corrob-
orated later on, as Dopwas shown to act as a depupylase, removing Pup
Fig. 3. Amino acid sequence alignment of Pup from different actinobacterial species. Conserved residues are colored according to their chemical properties. The height of the bars
below the alignment indicates the degree of conservation. Note the characteristic pattern of hydrophobic and charged residues in the C-terminal half, a typical feature of
coiled-coils. Mtb—Mycobacterium tuberculosis H37Rv; Msm—Mycobacterium smegmatis MC2155; Mlep—Mycobacterium leprae TN; Rhodo—Rhodococcus sp. RHA1; Nfarc—Nocardia
farcinica IFM 10152; Nocardio—Nocardioides sp. JS614; Mluteus—Micrococcus luteus NCTC 2665; Arthro—Arthrobacter aurescens TC1; Renibac—Renibacterium salmoninarum ATCC
33209; Janibac—Janibacter sp. HTCC2649; Blin—Brevibacterium linens BL2; Krhizo—Kocuria rhizophila DC2201; Clgu—Corynebacterium glutamicum ATCC 13032; Scoel—Streptomyces
coelicolor A3_2; Frankia—Frankia sp. CcI3; Acell—Acidothermus cellulolyticus 11B; Tfusca—Thermobiﬁda fusca YX; Stropica—Salinispora tropica CNB440; Lepto—Leptospirillum sp.
Group II UBA; Badol—Biﬁdobacterium adolescentis L2-32; Kradio—Kineococcus radiotolerans SRS30216; Seryth—Saccharopolyspora erythraea NRRL 2338; Cdiph—Corynebacterium
diphtheriae NCTC 13129; Actino—Actinomyces odontolyticus ATCC 17982.
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Section 3.3. It should benoted that pupylation in vitro, unlike eukaryotic
ubiquitination, produces discrete bands of mono-pupylated substrates
(Fig. 1) [3]. The existence of poly-Pup-chains cannot be ruled out, but
seems to be strongly disfavored in vitro.
3.3. Depupylation—removing Pup from substrates
Ubiquitination, along with many other posttranslational modi-
ﬁcations, has for a long time been known to be a reversible process.
Deubiquitinases (DUBs), which are encoded in large numbers in eukary-
otic genomes, are the opposing force in the eukaryotic ubiquitination
cycle and thus provide a crucial element of regulation [53]. This led to
the speculation that such an opposing activity might also be present in
the bacterial pupylation system. Indeed it could be shown in two inde-
pendent studies that actinobacterial cell lysates harbor such an activity,
since Pup was removed from an exogenously added Pup-modiﬁed sub-
strate over time [4,5]. Strikingly, this depupylation activity could be
assigned unambiguously to the enzyme Dop. Lysates derived from
dop-deﬁcient mycobacteria do not possess a depupylation activity. Fur-
thermore, depupylation could be reconstituted in vitro using puriﬁed
components [4,5]. Thus, the Pup modiﬁcation pathway features a cycle
of opposing activities, pupylation by Pup ligase PafA and depupylation
by depupylase/deamidase Dop (Fig. 5). PafA catalyzes the conjugation
of Pup to substrates, whereas Dop removes Pup from substrates. Mass
spectrometry revealed that the cleavage occurs precisely at the
isopeptide bond between Pup and the substrate [5], providing direct ev-
idence that Pup and the substrate are chemically unchanged after a cycle
of pupylation and depupylation.
Initially mycobacterial Pup (PupQ) is fed into this cycle by de-
amidation of the C-terminal glutamine of Pup to glutamate (Fig. 5
and Section 3.2). This reaction is also carried out by Dop and is chemi-
cally similar to depupylation. In both cases, Dop catalyzes thenucleophilic attack of water on the terminal carbonyl atom of Pup, re-
leasing ammonium in the case of deamidation or the substrate lysine
in case of depupylation (Fig. 6).
Notably it was found that the AAA unfoldase Mpa/ARC can en-
hance depupylation through Dop in vitro [5] and in vivo [4], likely
by increasing the accessibility of the isopeptide bond through un-
folding of the Pup-modiﬁed substrate. This may constitute an addi-
tional function of Mpa/ARC besides feeding pupylated substrates
into the proteasome for degradation and may explain the fact that
some lineages (e.g. corynebacteria) encode ARC, PafA, Dop and Pup
but not the 20S proteasome. One could envision a regulatory role of
ARC/Mpa by segregating pupylated substrates from large complexes
or subcellular structures, in analogy to the ubiquitin-selective AAA
protein Cdc48/p97 [54]. To date there is no evidence that pupylated
substrates are degraded by other protease systems (like for example
the Clp protease). However, it cannot be excluded that pupylated
proteins, after being unfolded by ARC become substrates for other
proteases. Such a scenario could also lead to maintenance of the
proteasomal ATPase gene in the absence of the proteasomal subunits.
3.4. Dop and PafA, two homologous but distinct enzymes
3.4.1. A closer biochemical look at Dop and PafA
Investigation of the nucleotide requirements of Dop and PafA pro-
vided further insight into the catalytic mechanism of the two enzymes.
Both the Dop- and PafA-catalyzed reactions were shown not to proceed
in a nucleotide-free buffer system [3]. Interestingly, Dop utilizes ATP
only as a cofactor, and the reaction also proceeds using ADP or the
non-hydrolyzable analog ATPγS, albeit much more slowly. By contrast,
PafA turns over one molecule of ATP to ADP per conjugation cycle,
suggesting that PafA activates Pup by phosphorylation of its C-terminal
glutamate [3] (Fig. 4). This is different from the activation step in
ubiquitination, which occurs through adenylation of Ub (and hence
Fig. 4. Reaction scheme of ubiquitination in eukaryotes and the bacterial pupylation pathway. Despite the different chemistry and different enzymes involved, functionally related stages
in the modiﬁcation pathway can be distinguished. In an initial preparation step, the tag is rendered competent for ligation. Ubiquitin precursors are C-terminally processed to expose a
di-glycine motif before they can be attached to target proteins. Similarly, mycobacterial Pup is rendered competent for conjugation by Dop via deamidation at its C-terminal glutamine.
During the subsequent activation step, the carboxylate has to be activated for the nucleophilic attack of the ε-amino group of the lysine residue. In ubiquitination, a ubiquitin-activating
enzyme E1 adenylates the C-terminal glycine residue to form a high-energy ubiquitin–AMP intermediate. The intermediate is subsequently passed to a catalytic cysteine thereby forming
a thioester linkage (not shown). Pup is activated by PafA through phosphorylation of its C-terminal glutamate to form a mixed anhydride. In the ﬁnal ligation step, nucleophilic attack of
the lysine on the activated carboxylate leads to formation of an isopeptide bond. This process is mediated by one of the many E3-ligases in ubiquitination and by the Pup ligase PafA in
pupylation. USP, ubiquitin-speciﬁc protease; UCH, ubiquitin C-terminal hydrolase.
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reaction cycle provided direct evidence for a phosphorylated Pup
intermediate [55]. The formation of this intermediate occurs even in
the absence of substrate and was shown to be the rate-limiting step of
the PafA catalyzed reaction. After activation, the phosphorylated Pup
and ADP remain bound to PafA, awaiting the nucleophilic attack of
the substrate lysine, which ﬁnally results in the formation of the
isopeptide bond [55]. Ub is linked to the ε-amino group of the
substrate lysine through its C-terminal glycine carboxylate. The
C-terminal residue of the ligation-competent PupE, however,
features two carboxylates, the C-terminal α-carboxylate and the
γ-carboxylate of the glutamyl side chain, both of which could in
principle be used for Pup-attachment. NMR-experiments using the
pupylated proteasomal substrate PanB clearly showed that only the
γ-carboxylate is used to form the isopeptide bond between Pup
and the target [56] (Fig. 4).
3.4.2. Structural insights into pupylation and depupylation
Recently, the structures of Dop and PafA were reported, showing
that the two enzymes are structurally homologous enzymes with dis-
tinct functions [3,7] (Fig. 6). Both feature a large N-terminal domain of
about 400 residues that shares its fold with other carboxylate-amine li-
gases [6,7] that likely constitute the evolutionary ancestor. The smaller
C-terminal domain of about 70 residues is unique to the Dop/PafA fam-
ily. The active site of both enzymes is located on the curved-in side of asix-stranded β-sheet at the center of the large domain. Dop and PafA
both require ATP bound at the active site [3]. The adeninemoiety is bur-
ied in a pocket at the end of the β-sheet proximal to the small domain.
The tri-phosphate chain extends along the strands towards the other
end of the sheet. In the homologous structure of glutamine synthetase
[57,58], the glutamate binding site is located at that end of the sheet
with the α-carboxylate binding to a conserved arginine residue that is
also strictly conserved in Dop and PafA members. This suggests that
the C-terminal glutamine/glutamate of Pup binds in an equivalent posi-
tion in Dop and PafA [7].
The possible binding region of Pup on the enzymes has been investi-
gated by assessment of surface conservation, relative location to the ac-
tive site and the putative glutamate/glutamine binding region as well as
site-directed mutagenesis [7]. A very likely candidate is a roughly 25 Å
long conserved groove leading into the active site directly at theputative
glutamate/glutamine binding site. By deletion-mutation analysis the
Pup C-terminal region has been determined to be sufﬁcient for conjuga-
tion and NMR experiments identiﬁed this portion of the protein as the
PafA and Dop interaction region (see also Fig. 7A). It has, therefore,
been suggested that Pup binds into the conserved groove, pointing its
C-terminal residue into theβ-sheet at the putative glutamate/glutamine
binding site [7].
Although Dop and PafA catalyze opposing reactions [3–5], namely
the cleavage of a C\N bond in case of deamidation/depupylation and
formation of a C\N bond in case of pupylation, the close homology of
Fig. 5. The mycobacterial pupylation/depupylation cycle. Post-translational modiﬁcation of a target protein (gray) with prokaryotic ubiquitin-like protein Pup (red) is regulated by two
opposing enzymes, the Pup ligase PafA (blue, PDB ID: 4B0T) and the depupylaseDop (green, PDB ID: 4B0R). Interestingly, inmycobacteria thedepupylation enzymeDop is required also to
render PupQ competent for ligation by deamidating the C-terminal glutamine to glutamate. After this preparation step, the Pup ligase PafA catalyzes formation of the isopeptide bond
between theγ-carboxylate of Pup's C-terminal glutamate and the ε-amino group of the substrate. The pupylated substrate (PDB ID: 2QJ3) can then be recruited to the coiled-coil domains
of the proteasomal ATPase Mpa (PDB ID: 3M9B).
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of their reactions, Dop and PafA bind similar substrates (PupQ or
Pup-substrate versus PupE and substrate) and feature as a related
reaction step the nucleophilic attack on the carbonyl carbon of the
C-terminal Pup residue (Fig. 6, lower panel). In the case of Dop,
water acts as the nucleophile to attack the carbonyl carbon, substitut-
ing either the amino group of the glutamine in deamidation (releas-
ing ammonia) [3] or the lysyl-substrate moiety in depupylation
(releasing the substrate-lysine) [4,5]. In the reaction catalyzed by
the Pup-ligase PafA, the step following activation through phosphor-
ylation of PupE is a nucleophilic attack of the ε-amino group of lysine
on the carbonyl carbon of phospho-Pup, leading to release of inor-
ganic phosphate [55]. It has been proposed that a loop between
two strands of the β-sheet is strategically located to provide catalytic
assistance to the nucleophilic attack [7]. A strictly conserved aspar-
tate in this loop, that is essential for activity in both enzymes, has
been proposed to act as catalytic base activating water or the
ε-amino group of lysine [7,59]. A recent study on the reaction
mechanism of Dop using a Pup variant chemically modiﬁed with
a glutamine-mimic even proposes that this aspartate might beinvolved in direct nucleophilic attack to form a covalent anhydride
intermediate [59].
4. Degradation of pupylated substrates by the mycobacterial
proteasome complex
4.1. Recruitment of pupylated substrates to the proteasome complex
leads to their ATP-dependent degradation
Pup serves as a recognition tag for proteasomal degradation,
directing substrates to the Mpa–proteasome degradation machinery.
The AAA partners of energy-dependent proteases commonly function
as the recognition platform for degradation substrates [20]. This is also
the case for Pup. In fact, Pup was originally found in a bacterial two-
hybrid screen setup to identify interaction partners of the proteasomal
ATPase Mpa [2]. Furthermore, pull-down analysis with Pup-decorated
beads using mycobacterial cell lysate as prey revealed Mpa as a major
interaction partner of Pup [3]. Further dissection of this interaction
demonstrated that Pup residues 21–58 interact with the coiled-coil do-
mains protruding from theMpamain ring-body [8] (Fig. 7). This portion
Fig. 6. Depupylase/deamidase Dop and Pup ligase PafA are structural homologs that catalyze opposing reactions but might use related catalytic mechanisms. Both Dop (PDB ID:
4B0R) and PafA (PDB ID: 4B0T) have a globular shape and consist of two tightly interacting domains: a larger N-terminal domain (about 400 residues) and a small C-terminal do-
main (about 70 residues). The N-terminal domain is homologous to the carboxylate-amine ligase family, while the C-terminal domain is unique to the Dop/PafA family and does not
exist in the other carboxylate-amine ligase family members. The large domain features a twisted, central β-sheet packing against a cluster of helices. The concave surface of the
sheet presents the active site of the enzyme and contains many conserved residues. Dop and PafA catalyze opposing reactions. Dop removes ammonia or the substrate lysyl moiety
from Pup while PafA ligates Pup to lysines. A strictly conserved aspartate residue in the active site of both enzymes has been proposed to assist in the nucleophilic attack of either
water (Dop) or the ε-amino group of lysine (PafA) on the carbonyl carbon.
Fig. 7. Pup binds to the Mpa coiled-coil domains and is engaged into the Mpa pore by its N-terminal unstructured region. A) Regions of Pup which map directly to its primary struc-
ture are responsible for distinct functional interactions. The region of Pup binding to the Mpa coiled-coil domain is highlighted in blue and partially overlaps with the docking region
for PafA (see brackets). The unstructured N-terminal region mediating engagement into the pore is highlighted in yellow. The ﬂexible C-terminal end (shown in red) is where
conjugation to substrates occurs. B) Cartoon depicting the docking of Pup to Mpa via its central helical region and engagement of the N-terminal Pup tail into the Mpa channel.
Loops lining the channel are thought to mediate unfolding and translocation. C) Structure of the Mpa interdomain (Mpa-ID) with a C-terminal fragment of Pup bound to the
Mpa coiled-coil region (Mpa-CC) (PDB ID: 3M9D) [9]. Mpa is shown in orange, Pup is depicted in blue.
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tent with weak helix formation, implying that a shared coiled-coil oc-
curs upon binding of Pup to Mpa [8]. A subsequent crystallographic
study conﬁrmed this notion showing that a C-terminal fragment of
Pup (residues 21–64) adopts a helical conformation upon binding to
the Mpa coiled-coil domain resulting in the formation of a shared
coiled-coil [9] (Fig. 7C). Notably, although three possible docking sites
are available, only one Pup appears to bind perMpa-ring. In comparison
with the isolated coiled-coil domains the presence of multiple docking
sites per ring-surface provides tighter binding due to avidity [8].
Access to the protease active sites requires threading through
the Mpa-ring pore. Like other AAA protease complexes [3], Mpa uses
ATPase-drivenmovements of conserved pore-loops that feature an aro-
matic residue to translocate the pupylated substrate along the Mpa
central channel, thereby unfolding it [10]. This unfoldase activity how-
ever only leads to subsequent degradation when the Mpa-ring and
the proteasomephysically interact. Asmentioned in Section 2.2, interac-
tion between Mpa and the full-length proteasome is exceedingly weak
in vitro. This likely prevents any substantial degradation activity, unless
an open-gate proteasomevariant is used that lacks theN-terminal seven
residues of the α-subunit [10,41]. Although Pup is naturally attached
to substrates via an isopeptide bond, model substrates where Pup is
N-terminally fused to the substrate through a regular peptide bond are
also degraded by the Mpa–proteasome complex [10,60].
Ubiquitin is usually recycled from polyubiquitinated substrates
upon processing by the eukaryotic 26S proteasome (Fig. 1) [61]. In
contrast to that Pup is degraded along with the substrate during in
vitro degradation assays [10]. It remains to be elucidated if this also
holds true in vivo.4.2. Pup provides signals for docking and feeding
The NMR titration studies probing the interaction of the Mpa
coiled-coil domain with Pup clearly demonstrated that the unstruc-
tured N-terminal region of Pup does not contribute to the binding inter-
actions with Mpa [8]. Though substrates that are modiﬁed with an
N-terminally truncated variant of Pup are still recruited to the Mpa–
proteasome, the N-terminal segment is strictly required for substrate
unfolding and degradation [10,60]. This led to the hypothesis that the
unstructured and poorly conserved N-terminal tail of Pup might be
needed to engage the substrate into the Mpa pore, to traverse the
interdomain and to make contact the conserved pore loops of the AAA
domain [8,10]. This notion was further supported by the fact that the
length of theN-terminal segment rather than the sequence is important
for substrate processing [10]. Interestingly, it has beendemonstrated for
the UPS that polyubiquitination of a substrate is not sufﬁcient for efﬁ-
cient degradation. In addition, an unstructured “initiation site” must
exist on the substrate in order to trigger unfolding and threading into
the ATPase pore [62,63]. The bacterial pupylation system appears to
combine these two recruitment determinants in one tag [10,60]. The
central region of Pup recruits the substrate to the proteasome by
docking onto the Mpa coiled-coil domains while the N-terminal un-
structured region reaches down into the Mpa pore to make contact
with the conserved pore loops and initiate unfolding (Fig. 7B). The crys-
tal structure of the Pup–Mpa–ID domain complex revealed that the Pup
helix aligns with the Mpa coiled-coil in such a way that the N-terminus
of Pup points down into the pore, an ideal geometric arrangement to fa-
cilitate threading [9].
Taken together, multiple studies show that Pup is a multifunctional
protein modiﬁer with several built-in functional regions that map di-
rectly to its primary sequence for read-out: the ﬂexible C-terminal con-
jugation element (GGQ/GGE) is required for reaching into the Dop and
PafA active sites and it allows covalent attachment to a large substrate
clientele; the central region acts as docking element to the proteasomal
ATPase Mpa (residues 20–58) as well as to the pupylation enzymes(residues 38–59); the N-terminal unstructured region provides the
threading element for unfolding by Mpa.
4.3. Regulation of the mycobacterial proteasome complex by pupylation
Proteomic studies onMtb andMsm aimed at the identiﬁcation of the
pupylated substrate proteome (also referred to as the “pupylome”), re-
vealed that the proteasomal ATPase Mpa itself is pupylated in vivo
[17,64,65]. This suggests an auto-regulatory functionwithin the PPS. In-
terestingly, the lysine residue ofMtbMpa (K591) that is modiﬁed with
Pup [17], is located near the C-terminal end of Mpa that interacts with
the proteasome core particle. Pupylation studies on Mpa carried out in
vitro showed that the pupylated Mpa hexamer can no longer interact
with the open-gate proteasome [66]. The pupylated, isolated Mpa-
rings then recruit each other via binding of the attached Pup to the
coiled-coils, leading to dissociation of the Mpa hexamers through a
threading/unfolding mechanism. Depupylation catalyzed by Dop can
fully reverse this pupylation-induced inactivation/disassembly [66]. It
is notable in this context that the Mpa lysine targeted by pupylation
is present only in those actinobacterial members that also harbor
proteasomal subunits, i.e. where the degradation branch exists. This
suggests that pupylation of Mpa is speciﬁcally connected to regulation
of Pup-dependent degradation. Pupylationmay thus have a role beyond
targeting proteins for degradation, e.g. by regulating protein–protein
interactions or enzyme activity.
5. Role of the Pup–proteasome-system in pathogenesis
Despite the signiﬁcant progress made in understanding the activ-
ities and mechanism of the pupylation pathway, the principles under-
lying the role played by the PPS in the pathogenesis of Mtb are not
fully understood to date. The organism's peculiar lifestyle is obviously
supported by multiple determinants. This is not least reﬂected by the
large number of genes that were predicted to be essential for growth
and persistence in mice [67]. The following section will give a short
overview about the current understanding of the probable involve-
ment of the Pup–proteasome system in Mtb pathogenesis.
The signiﬁcance of the Pup–proteasome systemwas ﬁrst implied by
a study that predicted the genes coding for the 20S proteasome, prcB
and prcA, to be essential forMtb in vivo growth [67]. Several subsequent
investigations provided evidence that pupylation and themycobacterial
proteasome are crucial elements that support the organism's ability to
withstand clearance by the macrophages they reside in. One hallmark
of the defense repertoire of infected activated macrophages is the gen-
eration of NO by the INF-γ inducible nitric oxide synthase [68]. The
resulting nitrosative stress was shown to be an important factor to con-
trolMtb infection since mice that lack iNOS quickly succumb [68]. Nev-
ertheless, NO-dependent killing is not quantitative and some bacilli
evade eradication and persist. In order to identify genes that confer re-
sistance against NO and other reactive nitrogen intermediates (RNI) a
transposon library ofMtbwas screened for mutants that were sensitive
to nitrosative stress in vitro, i.e. exposure to acidiﬁed nitrite [16]. Inter-
estingly, several hypersensitive mutants carried transposon insertions
in the genes coding for the proteasomal AAA unfoldase Mpa and the
Pup-ligase PafA. These ﬁndings were further corroborated by the obser-
vation that mpa and pafA mutants failed to grow in bone marrow de-
rived murine macrophages. Furthermore, gene disruption of either
mpa or pafA was accompanied by the attenuation ofMtb virulence in a
mouse model of infection. This was reﬂected by an impairment of Mtb
growth in lungs, a less pronounced formation of nodules and a signiﬁ-
cantly prolonged survival time of mice infected with either of the mu-
tants [14,16,35,50,69]. Similar results were obtained when the genes
coding for the Mtb 20S proteasome were subjected to conditional si-
lencing or were deleted. These mutants likewise showed an increased
sensitivity to nitrosative stress in vitro [15,27]. Accordingly, cell counts
(as judged by colony forming units) dropped by almost four orders of
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Surprisingly, the wild type phenotype with respect to resistance to
NO and RNI could be restored by complementing the proteasomal dele-
tion mutant with genes encoding a proteolytically inactive variant of
the 20S proteasome (prcAB-T1A) [27]. In addition, the active site mu-
tant proteasome allowed for wild type-like growth in lungs of mice in
the initial phase of infection. Yet, for Mtb host persistence and long-
time survival a proteolytically active proteasome was indispensable.
The actual impact of the Pup–proteasome system and its involve-
ment in Mtb pathogenesis remain obscure. A conceivable function
could be the removal of proteins that were damaged by nitrosylation
and thus rendered nonfunctional. However, there is evidence that the
function of pupylation and the proteasome complex goes beyondmere-
ly conferring resistance to NO and RNI. This notion is supported by the
observation that mpa and pafAmutant strains of Mtb are attenuated in
iNOS-deﬁcient mice [16,35,50] that are otherwise highly susceptible
to Mtb wild type infection. Furthermore, the degree of attenuation of
an Mtb prcBA deletion mutant was identical in mice that were either
treated with an iNOS inhibitor or were treated with the inactive enan-
tiomer of the inhibitor [27]. Especially the latter observation is in
sharp contrast to the suggested involvement of the Pup–proteasome
system in resistance against NO and RNI and clearly excludes a role
exclusively dedicated to nitrosative stress. In eukaryotes, ubiquitin-
dependent protein degradation is largely involved in the regulation of
various cellular processes [44]. Analogously, Pup and themycobacterial
proteasome could orchestrate the necessary cellular changes in order
to withstand the host's immune response by e.g. removing negative
regulators of stress- and survival-relevant genes. Transcriptome analy-
ses of Mtb pafA and mpamutant strains identiﬁed a copper-responsive
regulon that is controlled by the repressor RicR [70]. Deletion of ricR
resulted in constitutive expression of the members of this regulon and
renderedMtb less susceptible to toxic concentrations of copper. Howev-
er, a link between the copper-inducible genes and pathogenicity still
lacks experimental veriﬁcation. Recently, proteomic analyses were con-
ducted in order to identify targets of pupylation in Mtb grown under
standard conditions [17]. The study showed that the modiﬁcation
with Pup affects a multitude of different proteins involved in various
pathways. Interestingly, several pathogenesis-associated proteins, like
Icl1 [71], Ino1 [72] or MtrA [73] are subjected to pupylation and were
shown to be degraded by the proteasome. However, whether this has
any regulatory implications in the course of infection or during persis-
tence needs to be further scrutinized.
5.1. Mycobacterial proteasomal degradation as a drug target
The emergence of multi-drug resistant and extremely drug resistant
Mtb strains is a major challenge for the future treatment of tuberculosis
and illustrates the need for new and alternative drugs. Based on its im-
portance for Mtb the mycobacterial proteasome was early on consid-
ered to be an interesting potential drug target. The Mtb proteasome
was shown to be inhibited by a variety of inhibitors [16,27,38,50,74], in-
cludingbortezomib,which is in clinical use for the treatment ofmultiple
myeloma [75]. However, none of these compounds exhibits appropriate
selectivity for the mycobacterial degradation machinery without also
affecting themammalian proteasome to an equal or even higher degree
[74,76]. This problem was tackled by a study screening a collection of
20,000 synthetic compounds for their ability to inhibit themycobacteri-
al proteasome [77]. Two inhibitors were identiﬁed, GL5 and HT1171,
that showed high selectivity for the mycobacterial proteasome and no
cytotoxic effects on mammalian cells even in the micromolar range. In-
terestingly, the oxathiazol-2-one compounds GL5 and HT1171 were
also able to kill Mtb that resided in a non-replicating state upon expo-
sure to NO [77]. Mass spectrometry analyses and crystal structures
of oxathiazol-2-one inhibitor-treated Mtb proteasomes revealed that
irreversible inactivation occurs by cyclocarbonylating the active site
threonine. Furthermore, binding of the inhibitors is accompanied by asigniﬁcant conformational change of the β-subunit. The resulting occlu-
sion of the substrate binding pocket likely prevents hydrolysis of an
inhibitor-threonine intermediate and thus supports irreversible threo-
nine cyclocarbonylation [77]. The residues that are involved in the
stabilization of the new conformation are not well conserved across
species and probably determine the preferential inhibition of the
Mtb proteasome by oxathiazol-2-one compounds over the human
proteasome [77]. Only recently fellutamide B was reported as a highly
potent inhibitor of the Mtb proteasome [78]. This compound was
shown to be approximately 1000-fold more effective in inhibiting Mtb
proteasomal activity than other peptide aldehydes tested in earlier
studies [38]. Fellutamide B also affects the human proteasome to a
comparable degree though with striking differences compared to its
bacterial counterpart concerning the inhibition mechanism and its ste-
reochemistry. Furthermore, unlike the Mtb proteasome, the human
degradation complex exhibited conformational changes upon inhibitor
binding.
6. Concluding remarks
Research on the Pup–proteasome system has taught us much about
this recently discovered pathway and has done away with the
preconceived notion that macromolecular, covalent protein tags are
used only by eukaryotes. Pupylation has demonstrated that not only
are bacteria using protein tags as post-translational modiﬁers, but they
have evolved this mode of tagging independently. This shows us once
again that nature will arrive at analogous solutions when confronted
with related problems. Although the bacterial 20S proteasome is clearly
homologous to its eukaryotic counterpart, pupylation as a targeting
mechanism is carried out by enzymes of different evolutionary origin
than those involved in ubiquitination. Except for its functional implica-
tions in proteasomal degradation the Pup-tag itself bears no relation to
Ub or Ub-like proteins. Beyond these mechanistic differences, one
other distinguishing property is the role of the PPS in the bacteria that
carry it. While in eukaryotes the Ub proteasome system is the main
route for cytosolic protein degradation, actinobacteria possess a number
of ubiquitous bacterial chaperone protease complexes that coexist with
the Pup–proteasome system. In fact, Pup-dependent degradation ap-
pears non-essential under most conditions tested to date. This points
to a rather more speciﬁc role of pupylation that becomes critical during
a speciﬁc set of environmental conditions or at a particular life stage.
What exactly these conditions might be is largely not understood. It is
unknownunderwhich conditions substrates aremore or less pupylated.
Such an analysismight provide some insight as to the role of pupylation.
The only indication we currently have stems from the pathogenesis-
related phenotype exhibited by Mtb, where the PPS clearly plays a role
for survival in the host. However, the cause of the advantage provided
by the PPS to Mtb during host persistence has not been discovered yet.
The pupylated proteomes reported recently have all been determined
in vitro under conditions where the PPS is non-essential. Thus, it
would be interesting to compare these data with conditions where the
PPS is crucial for Mtb, i.e. inside the macrophage. This approach might
help to answer the questionwhich of themany reported target proteins
constitute genuine in vivo substrates of pupylation andwhich are ﬁnally
truly important. Will those target proﬁles that might turn out to be
crucial for one organism be comparable to proﬁles of an organism
displaying a completely different lifestyle, e.g. pathogenic versus non-
pathogenicmycobacteria? Considering the huge number of E3 ubiquitin
ligases in eukaryotes that speciﬁcally mediate the attachment of the tag
to the corresponding targets it is intriguing that only one ligase, PafA,
seems to be responsible for all the observed Pup-conjugation in bacteria.
The apparent lack of selectivity of the PPS is slightly reminiscent of
the eukaryotic SUMO-system, in which only a small number of E3-
enzymes are found [79] and “protein groups” rather than individual sub-
strates seem to bemodiﬁed [80]. Pupylation could be ameans of globally
combating damage to the proteome under stress conditions and would
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natively, we might still not have identiﬁed all the players involved.
Additional protein factors could bring selectivity to a system with an
otherwise broad substrate clientele. These points are also important
from a mechanistic perspective. How are substrates recognized by the
Pup ligase and what makes them good substrates for the depupylase?
When are substrates fed into the degradative branch of the system, i.e.
targeted to the proteasome, andwhen are they rescued fromdestruction
by depupylation?
It is clear that many exciting questions still remain to be answered
and that not all lessons have yet been learned from the Pup–proteasome
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